Bladder pain syndrome/interstitial cystitis research takes new directions

Advances in the field of bladder pain syndrome/interstitial cystitis will improve the ability of the practicing urologist to help patients with this problem.

Evolution of ureteral stents: Work is still needed

Several approaches have been taken to attenuate lower urinary tract symptoms and improve quality of life in the stented patient.

Bladder cancer data must be taken in context

New bladder cancer data are food for thought, but are not conclusive proof that urologists are over-treating early-stage bladder cancer and running up costs.

Mid-urethral slings: What have we learned?

It is clear from our collective sling experience that we can symptomatically improve continence for a durable length of time with minimal morbidity.

Prostate cancer chemoprevention: What's the next step?

Further analysis of the REDUCE (Reduction by Dutasteride of Prostate Cancer Events) trial will help answer important questions and direct therapy.

Injectable agents may expand options for BPH

While medical therapy remains the mainstay of treatment for most men with symptomatic BPH and surgery is required for severe, progressive disease, injectables may offer a number of theoretical advantages.

Single-port surgery: Is laparo-endoscopic single-site surgery really more?

Testosterone replacement therapy: The focus is shifting

Hypogonadism, or low serum testosterone, is associated with the unpleasant sequelæ of fatigue, low sex drive, diminished erections, and an increased tendency for fractures due to decreased bone mineral density.

Treatment of small renal masses: Quality or quantity of life?

The practicing urologist faces an increasingly common dilemma: How should I treat this incidentally discovered small renal mass?